Propanc Biopharma (PPCB) Accounts Payables (2011 - 2026)
Propanc Biopharma (PPCB) reported Accounts Payables of $1.13 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 23.9% from $1.49 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Accounts Payables (2011 - 2026) Analysis & Trends
Dating back to fiscal Q4 2011, Propanc Biopharma's Accounts Payables record includes 56 quarters.
- Accounts Payables has a five-year compound annual growth rate of 2.5% (FY2021 to FY2026).
- By fiscal year, Accounts Payables came in at $1.49 million in FY2025 (+22.5%), $1.21 million in FY2024 (+25.5%), $966,718 in FY2023 (+2.5%) and $943,023 in FY2022 (-5.9%).
- Five-year quarterly Accounts Payables spans a low of $826,184 in fiscal Q1 2022 and a high of $1.49 million in fiscal Q4 2025.
- Year over year, Accounts Payables gained in three of the last seven quarters, with an average decline of 3.1%.
- The high point for year-over-year Accounts Payables in five years was fiscal Q3 2024 (growth of 29.4%); the low point was fiscal Q4 2026 (a decline of 23.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Propanc Biopharma | 357,002.35 | -1.65 Mn | - | 1.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Dec 31, 2025 | 957,483.00 |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 966,718.00 |
| Mar 31, 2023 | 918,195.00 |
| Dec 31, 2022 | 914,491.00 |
| Sep 30, 2022 | 899,225.00 |
| Jun 30, 2022 | 943,023.00 |
| Mar 31, 2022 | 967,213.00 |
| Dec 31, 2021 | 920,692.00 |
| Sep 30, 2021 | 826,184.00 |
| Jun 30, 2021 | 1.00 Mn |
API Access
Propanc Biopharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();